{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T16:41:12Z","timestamp":1756572072970,"version":"3.40.5"},"reference-count":22,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,1,1]]},"abstract":"<jats:p>Objective. Conflicting reports have noted a possible association linking eradication of Helicobacter pylori with aggravation of gastroesophageal reflux (GER) disease. We prospectively evaluated the effect of eradication of H pylori on GER symptoms and epigastric pain and the association among these 3 parameters in a pediatric cohort.<\/jats:p>\n               <jats:p>Methods. Patients who were referred for gastroscopy were evaluated for frequency, severity, and nocturnal presence of symptoms related to GER as well as epigastric pain. Patients who were positive for H pylori received triple antibiotic therapy. The patients were followed for at least 6 months after therapy. Patients with successful eradication had symptoms compared with their pre-eradication state and were compared with a cohort of patients without H pylori or those with persistent H pylori.<\/jats:p>\n               <jats:p>Results. Of 119 children and adolescents who were recruited, 95 patients completed the study, with a mean follow-up of 11.2 months. The distribution of outcomes for each GER symptom (better, worse, unchanged) was similar before and after eradication and did not depend on prior H pylori status. Among patients with GER and epigastric pain, improvement in epigastric pain was significantly correlated with the improvement in GER symptoms but not with eradication of H pylori.<\/jats:p>\n               <jats:p>Conclusions. Eradication of H pylori is not associated with increased symptoms of GER in children and adolescents. Improvement in epigastric pain in children is significantly correlated with the improvement in GER symptoms but not with eradication of H pylori.<\/jats:p>","DOI":"10.1542\/peds.113.1.54","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:53:04Z","timestamp":1092444784000},"page":"54-58","source":"Crossref","is-referenced-by-count":45,"title":["Influence of <i>Helicobacter pylori<\/i> Eradication on Gastroesophageal Reflux Symptoms and Epigastric Pain in Children and Adolescents"],"prefix":"10.1542","volume":"113","author":[{"given":"Arie","family":"Levine","sequence":"first","affiliation":[{"name":"Pediatric Gastroenterology Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamir","family":"Milo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efrat","family":"Broide","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology Unit, Assaf Harofe Medical Center, Holon, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eitan","family":"Wine","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilan","family":"Dalal","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Boaz","sequence":"additional","affiliation":[{"name":"Epidemiology Unit, Edith Wolfson Medical Center, Holon, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yona","family":"Avni","sequence":"additional","affiliation":[{"name":"Gastroenterology Division"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haim","family":"Shirin","sequence":"additional","affiliation":[{"name":"Gastroenterology Division"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2004,1,1]]},"reference":[{"key":"2021121006083006200_R1","doi-asserted-by":"crossref","unstructured":"Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter pylori Study Group. Gut.1997;41:8\u201313","DOI":"10.1136\/gut.41.1.8"},{"key":"2021121006083006200_R2","unstructured":"Parsonnet J. The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther.1995;99(suppl 2):45\u201351"},{"key":"2021121006083006200_R3","unstructured":"Schistosomes, liver flukes, and Helicobacter pylori.\u2008IARC Monogr Eval Carcinog Risks Hum.1994;61:1\u2013241"},{"key":"2021121006083006200_R4","doi-asserted-by":"crossref","unstructured":"Labenz J, Blum A, Bayerdorfer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology.1997;112:1442\u20131447","DOI":"10.1016\/S0016-5085(97)70024-6"},{"key":"2021121006083006200_R5","doi-asserted-by":"crossref","unstructured":"Fallone C, Barkun A, Freidman G, et al. Is Helicobacter pylori infection eradication associated with gastroesophageal reflux disease?Am J Gastroenterol.2000;95:914\u2013920","DOI":"10.1111\/j.1572-0241.2000.01929.x"},{"key":"2021121006083006200_R6","doi-asserted-by":"crossref","unstructured":"Vakil N, Hahn B, Mcsorley D. Recurrent symptoms and gastroesophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori infection. Aliment Pharmacol Ther. 2000;14:45\u201351","DOI":"10.1046\/j.1365-2036.2000.00677.x"},{"key":"2021121006083006200_R7","unstructured":"Mihara M, Haruma K, Kamade T, et al. Low prevalence of Helicobacter pylori infection in patients with reflux esophagitis. Gut.1996;39(suppl 2):A94 (abstr)"},{"key":"2021121006083006200_R8","doi-asserted-by":"crossref","unstructured":"Koike T, Ohara S, Sekine H, et al. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut.2001;49:319\u2013320 (abstr)","DOI":"10.1136\/gut.49.3.330"},{"key":"2021121006083006200_R9","doi-asserted-by":"crossref","unstructured":"Wu J, Sung J, Chan F, et al. Helicobacter pylori infection is associated with milder gastro-esophageal reflux disease. Aliment Pharmacol Ther.2000;14:427\u2013432","DOI":"10.1046\/j.1365-2036.2000.00714.x"},{"key":"2021121006083006200_R10","doi-asserted-by":"crossref","unstructured":"Moayyedi P, Bardhan C, Young L, Dixon MF, Brown L, Axon AT. Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology.2001;121:1120\u20131126","DOI":"10.1053\/gast.2001.29332"},{"key":"2021121006083006200_R11","doi-asserted-by":"crossref","unstructured":"Laine L, Sugg J. Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: post hoc analysis of eight double blind prospective studies. Am J Gastroenterol.2002:97;2992\u20132997","DOI":"10.1111\/j.1572-0241.2002.07116.x"},{"key":"2021121006083006200_R12","doi-asserted-by":"crossref","unstructured":"McColl K, Dickson A, El-Nujumi A, El-Omar E, Kelman A. Symptomatic benefit 1\u20133 years after Helicobacter pylori eradication in ulcer patients: impact of gastroesophageal reflux disease. Am J Gastroenterol.2000;95:101\u2013105","DOI":"10.1111\/j.1572-0241.2000.01706.x"},{"key":"2021121006083006200_R13","doi-asserted-by":"crossref","unstructured":"Schwizer W, Thumshirn M, Dent J, et al. Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomized controlled trial. Lancet.2001;357:1738\u20131742","DOI":"10.1016\/S0140-6736(00)04894-7"},{"key":"2021121006083006200_R14","unstructured":"Rosioru C, Glassman MS, Halata MS, Schwartz SM. Esophagitis and Helicobacter pylori in children: incidence and therapeutic implications. Am J Gastroenterol.1993;88:510\u2013513"},{"key":"2021121006083006200_R15","doi-asserted-by":"crossref","unstructured":"Nelson SP, Chen EH, Syniar GM, Christoffel KK. Prevalence of symptoms of gastroesophageal reflux during childhood: a pediatric based survey. Arch Pediatr Adolesc Med.2000:154;150\u2013154","DOI":"10.1001\/archpedi.154.2.150"},{"key":"2021121006083006200_R16","doi-asserted-by":"crossref","unstructured":"Locke G, Talley N, Weaver A, Zinmeister A. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc.1994;69:539\u2013547","DOI":"10.1016\/S0025-6196(12)62245-9"},{"key":"2021121006083006200_R17","doi-asserted-by":"crossref","unstructured":"Dent J. Review article: is Helicobacter pylori relevant in the management of reflux disease?Aliment Pharmacol Ther.2001:15(suppl):16\u201321","DOI":"10.1046\/j.1365-2036.2001.00103.x"},{"key":"2021121006083006200_R18","doi-asserted-by":"crossref","unstructured":"Moayyedi P, Feltbower R, Brown J, et al. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Lancet.2000;355:1665\u20131669","DOI":"10.1016\/S0140-6736(00)02236-4"},{"key":"2021121006083006200_R19","doi-asserted-by":"crossref","unstructured":"Shaw M, Talley N, Beebe T, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol.2001;96:52\u201357","DOI":"10.1111\/j.1572-0241.2001.03451.x"},{"key":"2021121006083006200_R20","doi-asserted-by":"crossref","unstructured":"Klauser AG, Schindlbeck NE, Muller-Lissner A. Symptoms in gastro-oesophageal reflux disease. Lancet.1990;335:205\u2013208","DOI":"10.1016\/0140-6736(90)90287-F"},{"key":"2021121006083006200_R21","doi-asserted-by":"crossref","unstructured":"Locke G, Talley N, Fett S, Zinsmeister A, Melton L. Prevalence and clinical spectrum of gastroesophageal reflux: a population based study in Olmsted County, Minnesota. Gastroenterology.1997;112:1448\u20131456","DOI":"10.1016\/S0016-5085(97)70025-8"},{"key":"2021121006083006200_R22","doi-asserted-by":"crossref","unstructured":"Orenstein S. Gastroesophageal reflux. Pediatr Rev.1999;20:24\u201328","DOI":"10.1542\/pir.20.1.24"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/113\/1\/54\/889126\/zpe00104000054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/113\/1\/54\/889126\/zpe00104000054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T13:53:09Z","timestamp":1639144389000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/113\/1\/54\/63810\/Influence-of-Helicobacter-pylori-Eradication-on"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,1]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,1,1]]},"published-print":{"date-parts":[[2004,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.113.1.54","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2004,1,1]]}}}